HIV enters the brain and doesn't leave, drugs intended to reduce brain inflammation increase virus levels
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
7
See also stories tagged with HIV
Search results for hiv
Defective HIV copies explain most persistent traces in blood following treatment, study finds
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of the virus that causes ...
Jun 8, 2026
0
23
Flu drugs show promise against cognitive decline
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and ...
Jun 5, 2026
0
27
Deep South HIV prevention care has gaps where patients need it most
A recent University of Mississippi study has identified hundreds of counties in the South where HIV prevention and health care may not be keeping pace with the local needs, leaving communities without resources to address ...
Jun 3, 2026
0
4
Life-changing benefits of hydroxyurea for sickle cell anemia affirmed by 10-year study
Fewer serious complications. Fewer hospitalizations and blood transfusions. Better growth and development. And a markedly lower risk of death from the complications of sickle cell anemia.
Jun 3, 2026
0
7
Study offers new evidence on role of health crises in driving housing instability and homelessness
Major health events increase the risk of housing instability and homelessness among Medicaid enrollees, according to a new study at Columbia University Mailman School of Public Health. These findings shed new light on the ...
Jun 3, 2026
0
3
Popular GLP-1 drug may slow down biological aging, analysis indicates
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
Jun 3, 2026
0
369
HIV in South Africa: Why rolling out a new shot will miss a critical group of men
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, ...
Jun 1, 2026
0
4
The link between HIV and chronic pain
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice ...
Jun 1, 2026
0
6
Chronic liver disease in Europe: A preventable crisis going undetected
Europe is facing a growing chronic liver disease threat, according to a new series published in The Lancet Regional Health—Europe, that engaged more than 75 co-authors from 30 countries and was led by the Barcelona Institute ...
May 25, 2026
0
5
